Abstract:BACKGROUND: Long non-coding RNAs (lncRNAs) are essential regulators for various human cancers. However, these lncRNAs need to be further classified for cancer. In the present study, we identified novel competing endogenous RNA (ceRNA) network for bladder cancer (BC) and explored the gene functions of the ceRNA regulatory network.METHODS: Differential gene expression analysis were performed on The Cancer Genome Atlas Urothelial Bladder Carcinoma (TCGA-BLCA) datasets to identify differentially expressed messenger RNAs (mRNAs), lncRNAs, and microRNAs (miRNAs). Based on the competing endogenous RNA (ceRNA) hypothesis, a lncRNA-miRNA-mRNA network was constructed using the StarBase database and visualization by Cytoscape software. Functional enrichment analyses of Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were performed via R package ClusterProfiler. The protein-protein interaction network was constructed by STRING database and visualization by Cytoscape. Finally, we used CIBERSORT and the TIMER database to analyze the immune infiltrations for BC.RESULTS: The regulatory network was constructed via TCGA BLCA cohort. The differential expressions of lncRNA, miRNA, and mRNA were 186, 200, and 2,661, respectively. There were 106 lncRNA, miRNA, and mRNA included in the ceRNA network. In this network, Calcium Voltage-gated Channel Auxiliary Subunit Alpha2delta1 (CACNA2D1, P<0.001), domain containing engulfment adaptor1 (GULP1, P=0.001), latent transforming growth factor beta binding protein 1 (LTBP1, P=0.006), myosin light chain kinase (MYLK, P=0.001), serpin family E member 2 (SERPINE2, P=0.002), spectrin beta non-erythrocytic 2 (SPTBN2, P=0.047), and hsa-miR-590-3p (P<0.001) significantly affected the prognosis of BC patients. Functional enrichment analyses showed that the biological functions included negative regulation of protein phosphorylation, cell morphogenesis, and sensory organ morphogenesis. Important cancer pathways of KEGG included parathyroid hormone synthesis secretion action, the notch signaling pathway, MAPK signaling pathway, the Rap1 signaling pathway, signaling pathways regulating the pluripotency of stem cells, and the transforming growth factor-β signaling pathway. Our findings demonstrated that the ceRNA network has important biological functions and a significant influence on the prognosis of BC.CONCLUSIONS: The lncRNA-miRNA-mRNA network constructed in the present study could provide useful insight into the underlying tumorigenesis of BC, and can determine new molecular biomarkers for the diagnosis and therapeutical treatment of BC.

Genetic Alteration and Prospective Signaling Pathways of Mir-517 A-3 P in Bladder Cancer : a Study Based on Mirna Sequencing Data and Bioinformatics Methods

Differential Expression and Functions of Mirnas in Bladder Cancer

Oncogenic Role of MIR516A in Human Bladder Cancer Was Mediated by Its Attenuating PHLPP2 Expression and BECN1-dependent Autophagy.

MiRNA‐516a Promotes Bladder Cancer Metastasis by Inhibiting MMP9 Protein Degradation Via the AKT/FOXO3A/SMURF1 Axis

Role of Downregulated Mir-133A-3p Expression in Bladder Cancer: a Bioinformatics Study

Role Of Mir-1 And Its Potential Regulation Of Signaling Pathways In Bladder Cancer: A Comprehensive Investigation Based On Tcga, Geo, Arrayexpress, And Bioinformatics Analysis

Oncogene Mir-187-5p is Associated with Cellular Proliferation, Migration, Invasion, Apoptosis and an Increased Risk of Recurrence in Bladder Cancer.

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

Overexpression of Mir-340 Inhibits Cell Proliferation and Induces Apoptosis of Human Bladder Cancer Via Targeting Glut-1

MiR-302b Regulates Cell Functions and Acts As a Potential Biomarker to Predict Recurrence in Bladder Cancer

Comprehensive Investigation of Aberrant Microrna Profiling in Bladder Cancer Tissues.

Expression And Potential Molecular Mechanisms Of Mir-204-5p In Breast Cancer, Based On Bioinformatics And A Meta-Analysis Of 2,306 Cases

Potential clinical application of microRNAs in bladder cancer

Clinical Value of Mir-101-3p and Biological Analysis of Its Prospective Targets in Breast Cancer: A Study Based on the Cancer Genome Atlas (TCGA) and Bioinformatics.

miRNAs involvement in the etiology and targeted therapy of bladder cancer: Interaction between signaling pathway

MicroRNA-671-3p Inhibits the Development of Breast Cancer: A Study Based on in Vitro Experiments, In-House Quantitative Polymerase Chain Reaction and Bioinformatics Analysis.

Mir-19A-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma Via Targeting THBS1

Identification of Micror-106B As a Prognostic Biomarker of P53-Like Bladder Cancers by ActMiR

Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer

LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway

CCND1, NOP14 and DNMT3B Are Involved in Mir‐502‐5p–mediated Inhibition of Cell Migration and Proliferation in Bladder Cancer